Rockmore Capital

Total investments

2

Average round size

5M

Portfolio companies

2

Exits

2

Areas of investment
BiotechnologyHealth CareMedicalBiopharma

Summary

The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the New York.

Besides them, we counted 1 critical employee of this fund in our database.

The usual cause for the fund is to invest in rounds with 8 partakers. The meaningful sponsors for the fund in investment in the same round are Iroquois Capital, Whalehaven Capital Fund, Rosalind Capital Partners. In the next rounds fund is usually obtained by Third Security.

The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2016. The important activity for fund was in 2009. The common things for fund are deals in the range of 5 - 10 millions dollars.

Among the most popular fund investment industries, there are Biotechnology, Medical. Besides, a startup needs to be aged more than 20 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline CEL-SCI, Soligenix

Show more

Investments analytics

Analytics

Total investments
2
Lead investments
0
Exits
2
Investments by industry
  • Medical (2)
  • Health Care (2)
  • Biotechnology (2)
  • Biopharma (1)
Investments by region
  • United States (2)
Peak activity year
2010

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
37
Group Appearance index
1.00
Avg. company exit year
29

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.